EGFR and glioblastoma: A recent proteogenomic analysis which compares pairs of primary versus recurrent tumors [121] demonstrated that the evolution of glioblastomas under the pressure of therapy results in the deactivation of EGFR signaling and the acquisition of signaling involved in neuronal function and synapse formation (both pre- and post-synaptic structure).